Tag

Tagged: prescribing guidelines

Sponsored
joined 9 years, 1 month ago

Rajiv Dhir

Deputy Chief Pharmacist, Wandsworth Clinical Commissioning Group; Clinical Champion, Diabetes UK

Rajiv Dhir is a pharmacist who works as Deputy Chief Pharmacist at Wandsworth Clinical Commissioning Group (CCG), London. He is also a Clinical Champion for Diabetes UK.

Since graduation from University of Brighton in 1993, he has held a variety of positions mainly in Primary Care. After completion of his pre-registration training at Boots the Chemists, he continued working there gaining more experience in different roles (relief pharmacist, store manager and Professional Development Pharmacist). In 1999, he completed his post-graduate diploma in Clininal Pharmacy and was awarded a distinction.

Rajiv has been a pharmacist for over 24 years. He started his career working in community pharmacy before working in various roles in primary care, before taking on a role as Deputy Chief Pharmacist at Wandsworth Clinical Commissioning Group. The main focus of this role is to maximise benefit and minimise risk associated with medicines, as well as making the best use of resources allocated for prescribing.

Rajiv has a specific interest in diabetes and has completed diploma level modules on diabetes in primary care at Kings College London. Being a member of the various local diabetes committees allows him to develop and shape policies to help patients and clinicians manage Type 2 diabetes. Recently he has been involved with working with GPs and nurses to overcome barriers to optimising treatment in patients with poorly controlled diabetes. The role involves engaging with healthcare professionals across all sectors, as well as with patients, to make a positive impact on patient care.

In his role as one of Diabetes UK Clinical Champions, Rajiv looks at prescribing in the frail and elderly population with Type 2 diabetes. The aim of the project is to reduce the risk of hypoglycaemia and treatment-related harm, for example fall-related fractures, and improve the quality of life for people with moderate or severe frailty.


view this profile